Stay updated on GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    No significant changes detected in the Study Details page; content and core data appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-31T00:25:43.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    - Added Locations: Arizona, California, Illinois, Michigan, New York, Ohio, Pennsylvania, Wisconsin; removed HHS Vulnerability Disclosure; Revision: v3.3.3.
    Difference
    1.0%
    Check dated 2025-12-23T22:08:02.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    No significant changes detected between the old and new screenshots of the Study Details page for NCT05130255.
    Difference
    0.1%
    Check dated 2025-12-09T19:02:33.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page revision was updated from v3.2.0 to v3.3.2. No substantive changes to trial details, eligibility criteria, contacts, or results are evident; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:20:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice and NIH operating status guidance from the page; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T07:11:01.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The old and new page screenshots show only minor visual/layout adjustments with no changes to core study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:10:11.000Z thumbnail image

Stay in the know with updates to GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page.